HighTower Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.28M Buy
13,914
+12,741
+1,086% +$6.09M 0.01% 1023
2025
Q4
$683K Buy
1,173
+46
+4% +$23.5K ﹤0.01% 2398
2025
Q3
$517K Sell
1,127
-230
-17% -$85.8K ﹤0.01% 2593
2025
Q2
$411K Sell
1,357
-66
-5% -$19.7K ﹤0.01% 2695
2025
Q1
$471K Sell
1,423
-54
-4% -$17.7K ﹤0.01% 2508
2024
Q4
$456K Sell
1,477
-199
-12% -$56K ﹤0.01% 2542
2024
Q3
$355K Sell
1,676
-108
-6% -$27.6K ﹤0.01% 2682
2024
Q2
$499K Buy
1,784
+394
+28% +$93.8K ﹤0.01% 2317
2024
Q1
$370K Buy
1,390
+487
+54% +$115K ﹤0.01% 2514
2023
Q4
$208K Buy
+903
New +$158K ﹤0.01% 2981
2023
Q1
Sell
-720
Closed -$208K 3566
2022
Q4
$208K Buy
+720
New +$70.4K ﹤0.01% 2747

Other funds holding MDGL